President Donald Trump commuted the sentences of two men serving federal time for marijuana convictions on Thursday, marking his latest clemency actions as the DEA advances its cannabis rescheduling process.
Jerry Haymon IV and Kevin Harden will see their sentences end immediately under the commutations, which put both men on track for release from federal custody. The timing coincides with ongoing administrative proceedings at the Drug Enforcement Administration to move cannabis from Schedule I to Schedule III under the Controlled Substances Act.
The clemency grants add to a growing list of marijuana-related pardons and commutations issued during Trump's current term. The president has positioned himself as more willing to use executive clemency power compared to his first administration, though the pace remains slower than some advocates hoped.
The Rescheduling Context
The DEA is currently reviewing a formal recommendation from the Department of Health and Human Services to reclassify cannabis as a Schedule III substance. That change would acknowledge accepted medical use and lower abuse potential compared to Schedule I drugs like heroin.
But rescheduling would not eliminate federal marijuana crimes or automatically free anyone currently incarcerated. The numbers tell the story: thousands remain in federal prison for cannabis offenses even as the government considers reducing the drug's legal classification. Individual clemency remains the only path to early release for those serving time under current federal marijuana laws.
The disconnect between evolving federal policy and existing convictions has frustrated criminal justice reform advocates. Moving cannabis to Schedule III would ease research restrictions and resolve some tax issues for state-legal businesses, yet federal possession and distribution charges would remain on the books.
Clemency by the Numbers
Trump has granted clemency to a handful of marijuana offenders since returning to office, but the scale pales compared to the federal prison population. The U.S. Sentencing Commission data shows more than 2,700 people were serving federal sentences for marijuana trafficking as of last year. Possession cases add to that total.
Presidential clemency operates independently from the rescheduling process. While HHS and DEA work through administrative procedures that could take months, executive action can free individuals immediately. But clemency decisions remain discretionary and case-by-case, with no systematic review of marijuana sentences.
The White House has not detailed the specific circumstances of Haymon's and Harden's convictions or sentences. Clemency grants typically come after Justice Department review and recommendations, though presidents maintain final authority.
What This Means for Industry
Cannabis businesses watching the rescheduling process see little direct connection to clemency actions. Schedule III status would preserve federal illegality for recreational cannabis while easing some regulatory burdens. The 280E tax provision barring business deductions for Schedule I and II substances would no longer apply, potentially saving compliant operators millions.
Market watchers note that piecemeal clemency and administrative rescheduling both reflect incremental federal movement on cannabis policy. Neither addresses the fundamental conflict between state-legal markets operating in 38 states and continuing federal prohibition. Industry groups continue pushing for the SAFER Banking Act and full descheduling rather than Schedule III compromise.
The clemency announcements drew measured response from reform advocates who want broader action. Individual grants help specific people but leave systemic issues untouched. And rescheduling, while significant for research and business, would not resolve the core legal contradictions facing the cannabis sector.
This article is based on original reporting by www.marijuanamoment.net.
